CDNA expression analysis of a human radiosensitive-radioresistant cell line model identifies telomere function as a hallmark of radioresistance

Radiation Research

Volumn 174, Issue 5, 2010, Pages 550-557

  Zhou, Fu Xiang ^a   Xiong, Jie ^b   Luo, Zhi Guo ^b   Dai, Jing ^a   Yu, Hai Jun ^b   Liao, Zheng Kai ^a   Lei, Han ^b   Xie, Cong Hua ^a   Zhou, Yun Feng ^a  

^a WUHAN UNIVERSITY   (China)

^b Hubei Key Laboratory of Tumor Biological Behaviors and Hubei Cancer Clinical Study Center   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; PROTEIN POT1; TELOMERASE; TELOMERE BINDING PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE; CELL PROLIFERATION; CELL STRUCTURE; DNA MICROARRAY; DNA REPAIR; GENE EXPRESSION; HUMAN; HUMAN CELL; LARYNX CARCINOMA; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIOSENSITIVITY; SQUAMOUS CELL CARCINOMA; TELOMERE;

CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION PROFILING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RADIATION TOLERANCE; TELOMERASE; TELOMERE;

EID: 77958090127     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR1657.1     Document Type: Article

References (41)

1. E. Dikomey, J. Dahm-Daphi, I. Brammer, R. Martensen and B. Kaina, Correlation between cellular radiosensitivity and nonrepaired double-strand breaks studied in nine mammalian cell lines. Int. J. Radiat. Biol. 73, 269-278 (1998).
2. L. M. Hefferin and E. A. Tomkinson, Mechanism of DNA double-strand break repair by non-homologous end joining. DNA Repair (Amst.) 4, 639-648 (2005).
3. S. P. Lees-Miller, The DNA-dependent protein kinase, DNAPK: 10 years and no ends in sight. Biochem. Cell. Biol. 74, 503-512 (1996).
4. P. A. Jeggo, Identification of genes involved in repair of DNA double-strand breaks in mammalian cells. Radiat. Res. 150 (Suppl.), S80-S91 (1998).
5. J. M. Allalunis-Turner, K. P. Zia, M. G. Barron, R. Mirzayans and R. S. Day III, Radiation-induced DNA damage and repair in cells of a radiosensitive human malignant glioma cell line. Radiat. Res. 144, 288-293 (1995).
6. S. P. Lees-Miller, R. Godbout, W. D. Chan, M. Weinfeld, R. S. Day III, M. G. Barron and J. Allalunis-Turner, Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line. Science 267, 1183-1185(1995).
7. P. Slijepcevic, Is there a link between telomere maintenance and radiosensitivity? Radiat. Res. 160, 82-86 (2004).
8. C. W. Greider and E. H. Blackburn, Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell. 43, 405-413 (1985).
9. C. W. Greider and E. H. Blackburn, The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell. 51, 887-898 (1987).
10. L. M. Colgin, K. Baran, P. Baumann, T. R. Cech and R. R. Reddel, Human POT1 facilitates telomere elongation by telomerase. Curr. Biol. 13, 942-946 (2003).
11. D. Loayza and T. De Lange, POT1 as a terminal transducer of TRF1 telomere length control. Nature 423, 1013-1018 (2003).
12. F. X. Zhou, Z. K. Liao, J. Dai, J. Xiong, C. H. Xie, Z. G. Luo, S. Q. Liu and Y. F. Zhou, Radiosensitization Effect of zidovudin on human malignant glioma cell. Biochem. Biophys. Res. Commun. 354, 351-356 (2007).
13. X. M. Ji, C. H. Xie, M. H. Fang, F. X. Zhou, W. J. Zhang, M. S. Zhang and Y. F. Zhou, Efficient inhibition of human telomerase activity by antisense oligonucleotides sensitizes cancer cells to radiotherapy. Acta Pharmacol. Sin. 27, 1185-1191 (2006).
14. N. Mistuhashi, T. Takahashi, H. Sakurai, M. Nozaki, T. Akimoto, M. Hasegawa, Y. Saito, H. Matsumoto, K. Higuchi and H. Niibe, A radioresistant variant cell line isolated from a radiosensitive rat yolk sac tumor cell line: different of early radiation-induced morphological changes, especially apoptosis. Int. J. Radiat. Biol. 69, 329-336 (1996).
15. J. U. Lee, R. Hosotani, M. Wada, R. Doi, T. Kosiba, K. Fujimoto, Y. Miyamoto, S. Tsuji, S. Nakajima and M. Imamura, Role of Bcl-2 family proteins (Bax, Bcl-2 and Bcl-x) on cellular susceptibility to radiation in pancreatic cancer. Eur. J. Cancer 35, 1374-1380 (1999).
16. K. Wei, R. Kodym and C. Jin, Radioresistant cell strain of human fibrosarcoma cell obtained after long term exposure to X-rays. Radiat. Environ. Biophys. 37, 133-137 (1998).
17. C. M. Kang, H. N. Cho, J. M. Ahn, S. S. Lee, D. I. Jeoung, C. K. Cho, S. Bae, S. J. Lee and Y. S. Lee, Alteration of gene expression during radiation-induced resistance and tumorigenesis in NIH3T3 cells revealed by cDNA microarrays: involvement of MDM2 and CDC25B. Carcinogenesis 25, 123-132 (2004).
18. G. Z. Guo, Y. Y. Sanders, B. D. Lyn-Cook, T. Wang, D. Tamae, J. Ogi, A. Khaletskiy, Z. K. Li, C. Weydert and J. J. Li, Manganese superoxide dismutase-mediated gene expression in radiation-induced adaptive responses. Mol. Cell. Biol. 23, 2362-2378 (2003).
19. G. Iliakis, H. Wang, A. R. Perrault, W. Boecker, B. Rosidi, F. Windhofer, W. Wu, J. Guan, G. Terzoudi and G. Pantelias, Mechanisms of DNA double strand break repair and chromosome aberration formation. Cytogenet. Genome Res. 104, 14-20 (2004).
20. V. Smider, K. W. Rathmell, R. M. Lieber and G. Chu, Restoration of X-ray resistance and V(D)J recombination in mutant cells by Ku cDNA. Science 266, 288-291 (1994).
21. S. P. Lees-Miller, R. Godbout, W. D. Chan, M. Weinfeld, R. S. Day 3rd, M. G. Barron and J. Allalunis-Turner, Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line. Science 267, 1183-1185 (1995).
22. J. Gautier, J. M. Solomon, N. R. Booher, F. J. Bazan and W. M. Kirschner, cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2. Cell 67, 197-211 (1991).
23. J. M. Grossel and W. P. Hinds, From cell cycle to differentiation: an expanding role for cdk6. Cell Cycle 5, 266-270 (2006).
24. M. T. Pawlik and K. Keyomarsi, Role of cell cycle in mediating sensitivity to radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 59, 928-942 (2004).
25. K. D. Held, Radiation-induced apoptosis and its relationship to loss of clonogenic survival. Apoptosis 2, 265-282 (1997).
26. P. C. Burren, M. E. Wilson, V. Hwa, Y. Oh and G. R. Rosenfeld, Binding properties and distribution of insulin-like growth factor binding protein-related protein 3 (IGFBP-rP3/NovH), an additional member of the IGFBP superfamily. J. Clin. Endocrinol. Metab. 84, 1096-1103 (1999).
27. V. Joliot, C. Martinerie, G. Dambrine, G. Plassiart, M. Brisac, J. Crochet and B. Perbal, Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus type 1-induced nephroblastomas. Mol. Cell. Biol. 12, 10-21 (1992)
28. F. d'Adda di Fagagna, S. H. Teo and S. P. Jackson, Functional links between telomeres and proteins of the DNA-damage response. Genes Dev. 18, 1781-1799 (2004).
29. E. S. Artandi and D. L. Attardi, Pathways connecting telomeres and p53 in senescence, apoptosis, and cancer. Biochem. Biophys. Res. Commun. 33, 1881-890 (2005).
30. V. Gorbunova and A. Seluanov, Telomerase as a growth-promoting factor. Cell Cycle 2, 534-537 (2003).
31. T. Veldman, K. T. Etheridge and C. M. Counter, Loss of hPot1 function leads to telomere instability and a cut-like phenotype. Curr. Biol. 14, 2264-2270 (2004).
32. P. Baumann and R. T. Cech, Pot1, the putative telomere end-binding protein in fission yeast and humans. Science 292, 1171-1175 (2001).
33. T. Kondo, N. Oue, K. Yoshida, Y. Mitani, K. Naka, H. Nakayama and W. Yasui, Expression of POT1 is associated with tumor stage and telomere length in gastric carcinoma. Cancer Res. 64, 523-529 (2004).
34. B. Zhang, Y. X. Bai, H. H. Ma and F. Feng, Silencing PinX1 compromises telomere length maintenance as well as tumorigenicity in telomerase-positive human cancer cells. Cancer Res. 69, 75-83 (2009).
35. M. A. Rubio, S. H. Kim and J. Campisi, Reversible manipulation of telomerase expression and telomere length. Implications for the ionizing radiation response and replicative senescence of human cells. J. Biol. Chem. 277, 28609-28617 (2002).
36. J. McIlrath, S. Bouffler, A. Samper, A. Cuthbert, A. Wojcik, I. Szumiel, P. E. Bryant, A. Riches, A. Thompson and P. Slijepcevic, Telomere length abnormalities in mammalian radiosensitive cells. Cancer Res. 61, 912-915 (2001).
37. S. M. Bailey, J. Meyne, J. D. Chen, A. Kurimasa, G. C. Li, B. E. Lehnert and E. H. Goodwin, DNA double-strand break repair proteins are required to cap the ends of mammalian chromosomes. Proc. Natl. Acad. Sci. USA 96, 14899-14904 (1999).
38. F. A. Goytisolo, E. Samper, S. Edmonson, G. E. Taccioli and M. A. Blasco, The absence of the DNA-dependent protein kinase catalytic subunit in mice results in anaphase bridges and in increased telomeric fusions with normal telomere length and G-strand overhang. Mol. Cell. Biol. 21, 3642-3651 (2001).
39. D. Gilley, H. Tanaka, M. P. Hande, A. Kurimasa, G. C. Li, M. Oshimura and D. J. Chen, DNA-PKcs is critical for telomere capping. Proc. Natl. Acad. Sci. USA 98, 15084-15088 (2001).
40. S. M. Bailey, M. N. Cornforth, R. L. Ullrich and E. H. Goodwin, Dysfunctional mammalian telomeres join with DNA double-strand breaks. DNA Repair (Amst.) 3, 349-357 (2004).
41. P. Slijepcevic and S. Al-Wahiby, Telomere biology: integrating chromosomal end protection with DNA damage response. Chromosoma 114, 275-285 (2005).